FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib MedNews
MONDAY, May 4, 2026 The U.S. Food and Drug Administration (FDA) granted expanded access for the use of an experimental pancreatic cancer drug, daraxonrasib.This
The Cherokee Nation recently announced its elder nutrition sites in Nowata and Stilwell will be open five days a week, providing nutritious meals and a place to gather and fellowship Post Views: